Product image of Novantrone (Mitoxantrone) supplied by GNH India

Novantrone

Active Ingredient:
Mitoxantrone
Origin:
EU

Novantrone (Mitoxantrone)

Mitoxantrone, the active ingredient in Novantrone, is a anthracenedione antineoplastic presented as an injection for intravenous use. It treats acute myeloid leukemia, acute lymphoblastic leukemia, metastatic breast cancer and is used off‑label for multiple sclerosis in adult patients.

GNH India supplies Novantrone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Viatris As

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Novantrone (mitoxantrone) is employed in the treatment of hematologic malignancies and selected solid tumours.
  • Acute myeloid leukemia: induces remission by targeting rapidly dividing leukemic cells.
  • Acute lymphoblastic leukemia: contributes to disease control in relapsed or refractory cases.
  • Metastatic breast cancer: provides disease stabilization in patients with prior therapy.
  • Multiple sclerosis (off‑label): reduces relapse frequency in progressive forms.

How It Works

  • Mitoxantrone intercalates between DNA base pairs, stabilising the double helix and preventing the unwinding required for transcription. It also inhibits topoisomerase II, blocking the resealing of DNA strands during replication, which leads to accumulation of double‑strand breaks and triggers apoptosis in rapidly proliferating cells.

Side Effects

Mitoxantrone may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Fatigue: general tiredness.
  • Alopecia: temporary hair loss.
  • Myelosuppression: reduced blood cell counts.

Serious or Rare Side Effects

  • Cardiotoxicity: irreversible reduction in left ventricular ejection fraction.
  • Severe myelosuppression: neutropenia or thrombocytopenia leading to infection or bleeding.
  • Secondary leukemia: emergence of therapy‑related acute leukemia.
  • Severe hypersensitivity: anaphylactic reactions.

Precautions & Warnings

  • Key safety considerations should be observed when using Novantrone.
  • Monitor cardiac function: baseline and periodic echocardiograms are recommended.
  • Assess blood counts: regular CBC to detect myelosuppression.
  • Avoid use in pregnancy: drug is contraindicated due to fetal risk.
  • Use with caution in hepatic impairment: dose adjustment may be required.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Potential drug interactions require careful management.

Major Interactions (Avoid)

  • Anthracyclines: combined cardiotoxic risk may be additive.
  • Live vaccines: immunosuppression can increase infection risk.
  • CYP450 inhibitors: may increase mitoxantrone exposure (e.g., ketoconazole).
  • High-dose radiation therapy: enhanced tissue toxicity.

Moderate Interactions (Monitor Closely)

  • Anticoagulants: increased bleeding risk due to thrombocytopenia.
  • Other myelosuppressive agents: cumulative bone marrow suppression.
  • Hormonal therapies: potential additive effects on blood counts.

Frequently Asked Questions

Novantrone (mitoxantrone) is indicated for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia and metastatic breast cancer. In some regions it is also used off‑label for certain forms of multiple sclerosis.

Mitoxantrone intercalates into DNA and inhibits topoisomerase II, preventing DNA strand re‑ligation during replication. This causes double‑strand breaks, leading to apoptosis of rapidly dividing cancer cells.

The dose of Novantrone is set by the prescribing physician based on the specific indication, patient weight, renal and hepatic function, and prior treatment history. No standard dosing regimen is provided here.

Novantrone is classified as pregnancy category D, indicating evidence of fetal risk. It is generally contraindicated in pregnancy and not recommended during breastfeeding because it may be excreted in milk and harm the infant.

To order Novantrone, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Novantrone belongs to the anthracenedione subclass, sharing a DNA‑intercalating and topoisomerase‑II‑inhibiting mechanism with anthracyclines such as doxorubicin. Compared with traditional anthracyclines, mitoxantrone has a lower incidence of acute cardiotoxicity but still requires cardiac monitoring, especially at higher cumulative doses.

Novantrone should be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the solution before administration.

Novantrone is supplied as a sterile injectable solution for intravenous infusion. It is typically administered by a qualified healthcare professional in a clinical setting, following institutional protocols for infusion rate and monitoring.

The most serious risks include irreversible cardiotoxicity, severe myelosuppression leading to infection or bleeding, therapy‑related secondary leukemia, and severe hypersensitivity reactions such as anaphylaxis. Patients should be monitored closely for these events.

Novantrone is contraindicated in pregnant women, patients with pre‑existing severe cardiac disease, uncontrolled infections, and those with known hypersensitivity to mitoxantrone or any formulation component. Caution is also advised for individuals with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mitoxantrone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT